PMID: 16513041Mar 4, 2006Paper

Course and outcomes of depression in the elderly

Current Psychiatry Reports
Robert Kohn, Gary Epstein-Lubow

Abstract

Major depressive disorder is a potentially debilitating condition that often is unrecognized or undertreated in the elderly. Even when aggressively treated, the course of geriatric depression can be severe. There is growing evidence that suggests that late-life depression may carry a higher illness burden than depression with onset earlier in life, and that severity is linked to medical and psychiatric comorbidity. Data continue to accumulate in support of various treatment modalities, including medication, electroconvulsive therapy, and psychotherapy. Given the increased risk of adverse outcomes associated with geriatric depression, such as dementia and suicide, it is essential that future investigations continue to build on the evidence base supporting improved diagnosis and treatment of this complex disorder.

References

Nov 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·P MeatsD Jolley
Sep 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·L MusettiH S Akiskal
Jul 1, 1980·Acta Psychiatrica Scandinavica·R M Fraser, I B Glass
Apr 1, 1996·Archives of General Psychiatry·G S AlexopoulosE Rosendahl
Oct 24, 1997·Archives of General Psychiatry·G S AlexopoulosM Charlson
Aug 1, 1997·The Journal of Clinical Psychiatry·R A PhilibertG Winokur
Aug 12, 1998·The American Journal of Psychiatry·J T LittleD J Kupfer
Mar 11, 2000·Archives of General Psychiatry·G S AlexopoulosJ Hull
Feb 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·T A Tuma
Jun 6, 2000·Archives of General Psychiatry·D C SteffensJ C Breitner
Sep 1, 2000·Journal of Affective Disorders·H BrodatyL Prenter
Jun 19, 2001·The Cochrane Database of Systematic Reviews·K WilsonA Nightingale
Dec 12, 2001·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·M K O'ConnorC Kellner
Mar 7, 2002·Archives of General Psychiatry·Dennis S CharneyUNKNOWN Consensus Development Panel
May 7, 2002·The Australian and New Zealand Journal of Psychiatry·A F Jorm
Jul 2, 2002·Archives of General Psychiatry·Aartjan T F BeekmanWillem van Tilburg
Jul 3, 2002·American Journal of Preventive Medicine·Reiner Rugulies
Aug 17, 2002·Biological Psychiatry·Patricia A Areán, Beth L Cook
Nov 7, 2002·Archives of General Psychiatry·Mary GanguliBenoit H Mulsant
Nov 27, 2002·Journal of Affective Disorders·Pim Cuijpers, Filip Smit
Dec 11, 2002·JAMA : the Journal of the American Medical Association·Jürgen UnützerUNKNOWN IMPACT Investigators. Improving Mood-Promoting Access to Collaborative Treatment
Jan 28, 2003·Journal of Affective Disorders·Lars Vedel Kessing, Flemming Mørkeberg Nilsson
Mar 14, 2003·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Dan G Blazer
May 21, 2003·Archives of Neurology·Robert C GreenLindsay Farrer
Jun 5, 2003·The American Journal of Psychiatry·Martin G Cole, Nandini Dendukuri
Jun 14, 2003·The Cochrane Database of Systematic Reviews·F B Van der WurffA T Beekman
Jul 2, 2003·The American Journal of Psychiatry·Lon S SchneiderUNKNOWN Sertraline Elderly Depression Study Group
Aug 29, 2003·Journal of Affective Disorders·R A SchoeversW van Tilburg
Nov 13, 2003·Journal of Affective Disorders·Eric J LenzeCharles F Reynolds
Nov 19, 2003·Journal of Clinical Psychopharmacology·Raffaella ZanardiAlessandro Serretti
Dec 17, 2003·International Journal of Geriatric Psychiatry·Ernst BohlmeijerPim Cuijpers
Dec 23, 2003·Journal of the American Geriatrics Society·Lucy Rose FischerRichard L Heinrich
Jan 20, 2004·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Timothy I MuellerMartin B Keller
Jan 24, 2004·Current Psychiatry Reports·Amber Gum, Patricia A Areán
Jun 16, 2004·Annals of Internal Medicine·John W WilliamsUNKNOWN IMPACT Investigators
Sep 2, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Warren D Taylor, P Murali Doraiswamy
Sep 2, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Guy G PotterK Ranga Rama Krishnan
Sep 2, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George S AlexopoulosMoonseong Heo

❮ Previous
Next ❯

Citations

Jan 25, 2013·Zeitschrift für Gerontologie und Geriatrie·M A Rapp
Oct 6, 2010·The Journal of Nutrition, Health & Aging·G B RattingerS Delisle
Feb 19, 2013·Psychosomatics·Elizabeth VidalGlenn Catalano
Apr 29, 2011·Journal of Affective Disorders·Xiaoquan WangZhijun Zhang
Nov 28, 2008·Clinical Pharmacology and Therapeutics·Bg PollockRr Bies
May 3, 2008·Acta Psychiatrica Scandinavica·H J LuijendijkH Tiemeier
Apr 3, 2007·Journal of the American Geriatrics Society·Ethan M BerkeEric B Larson
Aug 23, 2016·Transport Policy·Richard J Lee, Ipek N Sener
Jun 11, 2014·Journal of the American Medical Directors Association·Hana VankovaAlexander Martin Celko
Aug 19, 2015·Translational Psychiatry·V JanuarJ Ryan
Jul 31, 2012·Journal of Affective Disorders·Melanie LuppaSteffi G Riedel-Heller
Mar 9, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Katharina Tigges-LimmerJan F Gummert
Feb 6, 2019·Journal of Market Access & Health Policy·François-Xavier LamyDelphine Saragoussi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.